ข่าวประชาสัมพันธ์Hypertension | newswit
OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day – OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection, and control. MMM was established by the
Combating Three Major Chronic Diseases in Central and South-East Asia With Medical Education – (Photo: http://photos.prnewswire.com/prnh/20150630/227090 ) Manage Diabetes Online [http://www.managediabetesonline.org ], Manage Hypertension Online [http://www.managehypertensiononline.org ] and Manage Thyroid Online [http://www.managethyroidonline.org ] - each developed and operated by EXCEMED [http://www.excemed.org ] -
Combating Three Major Chronic Diseases in Latin America With Medical Education – (Photo: http://photos.prnewswire.com/prnh/20150630/227033 ) Manage Diabetes Online [http://www.managediabetesonline.org ], Manage Hypertension Online [http://www.managehypertensiononline.org ] and Manage Thyroid Online [http://www.managethyroidonline.org ] - each developed and operated by EXCEMED [http://www.excemed.org ] - combine the
Spending Time with Your Dog may Help Lower Your Blood Pressure – The presence of a pet dog can significantly lower the blood pressure of its owner as they go about their day-to-day activities, new research by the University of Maryland has shown. The study, which was supported by funding from the WALTHAM(R) Centre for Pet Nutrition (WALTHAM(R)), looked at pet owners over 50 years of age with pre- to mild hypertension and
รพ. บำรุงราษฎร์ จัดกิจกรรมส่งเสริมความรู้ “ความดันคุมได้ หัวใจเต้นดี” เนื่องในวันความดันโลหิตสูงโลก – กรุงเทพฯ--8 พ.ค.--โรงพยาบาลบำรุงราษฎร์ โรงพยาบาลบำรุงราษฎร์ ขอเชิญท่านผู้สนใจเข้าร่วมกิจกรรมส่งเสริมความรู้เพื่อสุขภาพ “ความดันคุมได้ หัวใจเต้นดี” เนื่องในวันความดันโลหิตสูงโลก (World Hypertension Day) ในวันศุกร์ที่ 17 พฤษภาคม 2556 เวลา 9.00 – 14.00 น. ณ ล็อบบี้ อาคารบำรุงราษฎร์ อินเตอร์เนชั่นแนล คลินิก สุขุมวิท
Global Hypertension Experts Launch First-of-its-Kind Online Resource to Help Healthcare Professionals Address Most Challenging Form of Hypertension – Resource Endorsed by the American Society of Hypertension and the European Society of HypertensionThe Power Over Pressure steering committee today announced the launch of the world's first online resource created to help healthcare professionals improve diagnosis and develop
Late-Breaking Analysis in Hypertension Shows That Antihypertensive Treatments Differ in Their Ability to Preserve Lives – According to the results of a late-breaking analysis involving more than 200 000 patients who participated in recent clinical trials, antihypertensive treatments with renin-angiotensin system (RAS) inhibitors significantly differ in their ability to preserve lives.[1] This new analysis, presented today at the
Experts and Representatives From Leading International Health-Care Organizations Call to Stop the Hypertension Pandemic, a Worldwide Silent Killer – A Working Group of representatives from seven international health-care organizations call for improved blood pressure (BP) goal rate levels of patients with hypertension, the single most important cause of attributable mortality around the world. This has driven the working
More Than Half of Hypertensive Patients Remain Uncontrolled and at Higher Risk of Heart Attack and Stroke - Telmisartan May Decrease This Risk – - Results From Two Large, Multinational, Practice-BasedObservational Studies in Blood PressureNew data announced today at the Annual European Society of Hypertension (ESH) show that measuring blood pressure in a doctor's office alone does not provide an accurate picture of a
Amlodipine Based Regimen to Lower Blood Pressure, Reduces the Risk of New-Onset Diabetes in Hypertensive Patients by More Than a Third – Issued on behalf of the Executive Committee of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)A hypertension regimen based on the calcium channel blocker amlodipine has been shown to reduce the risk of new-onset diabetes by 34 percent in people with high blood pressure, compared with
Amlodipine Based Regimen to Lower Blood Pressure, Reduces the Risk of New-Onset Diabetes in Hypertensive Patients by More Than a Third – Issued on behalf of the Executive Committee of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)A hypertension regimen based on the calcium channel blocker amlodipine has been shown to reduce the risk of new-onset diabetes by 34 percent in people with high blood pressure, compared with
Actelion Launches Tracleer in in PAH Japan – Bangkok--Jul 8---PRIMEZONE MEDIA NETWORK Approved for All Forms of Pulmonary Arterial Hypertension—Full Reimbursement Status Granted Actelion Ltd (SWX: ATLN) (Other OTC:ALIOF) announced today that Tracleer ( r ) (bosentan) is now available upon prescription to all patients in Japan. In early April, the Japanese Ministry of Health, Labor and Welfare had granted formal approval
New Clinically Important BP Efficacy Data with Novartis' Antihypertensives Diovan & Co-Diovan Presented at Leading Hypertension Meeting – Study results show excellent BP efficacy reduction with Co-Diovanin difficult-to-treat patient populationNovartis' Co-Diovan(R) (valsartan and hydrochlorothiazide) aggressively lowers blood pressure to recommended target goals as effectively as amlodipine but with fewer side effects in
ผู้บุกเบิกการวิจัยเรื่องความดันโลหิตสูงได้รับรางวัลรางวัลสเตโว จูเลียส สำหรับการศึกษาเรื่องดังกล่าว – International Society Hypertension เป็นผู้นำเสนอ รางวัลอันทรงเกียรติสเตโว จูเลียสนี้ในวันนี้ มีการมอบรางวัลสเตโว จูเลียส (Stevo Julius Award) ให้แก่นายแพทย์ จอห์น ลาราห์ (John Laragh) และนายแพทย์เจเรมี สเตมเลอร์ (Jeremiah Stamler) ซึ่งมีชื่อเสียงไปทั่วโลกจากการทำวิจัยและสร้างความเข้าใจเกี่ยวกับโรคความดันโลหิตสูง
Stevo Julius Award for Education in Hypertension Granted to Two Pioneers in Hypertension Research – Prestigious Award Presented by the International Society of HypertensionJohn Laragh, MD and Jeremiah Stamler, MD, both known worldwide for their significant contributions to the research and understanding of hypertension,and the leadership they have provided to many young scientists,today received the Stevo Julius Award for